• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classicsâ„¢+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classicsâ„¢+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Expanding heart transplant in the era of direct-acting antiviral therapy for hepatitis C

byAliya Ramjaun
December 28, 2019
in Cardiology, Chronic Disease, Infectious Disease, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. The rate of hepatitis C virus (HCV) transmission from nucleic acid amplification testing (NAT)-negative donor hearts is low, and survival rates in patients with donor-derived HCV are high.

Evidence Rating Level: 2 (Good)

While there have been considerable advances in heart transplantation, more and more patients are becoming reliant on mechanical circulatory support (MCS) and are subject to increasing morbidity and mortality due to long wait times and a shortage of donor hearts. Studies examining the use of hepatitis C virus (HCV)-positive donors had previously demonstrated a high rate of HCV infection and poor outcomes in recipients. With the introduction of direct-acting antivirals (DAAs), however, there is renewed interest in using organs from HCV-positive donors. In this prospective cohort study, 80 patients that received a heart transplant from an HCV-positive donor (September 2016-April 2019) at a large academic center were followed up to determine whether the inclusion of HCV-positive donors increased the donor pool, impacted waitlist duration, and to better understand the transmission and cure of donor-derived hepatitis C, morbidity and mortality at 1 year post-transplant. Researchers found that the median active waitlist time from the time of consenting to accept a HCV-positive donor heart was 4 days (IQR 1 to 18 days). Of the patients that had accrued active waitlist time before being consented to receive an HCV-positive donor heart, the median waitlist time was 28 days (IQR 6 to 168 days). The transmission rate of HCV in patients that received a nucleic acid amplification testing (NAT)-positive donor heart was 95.7%. None of the 10 recipients of hearts from NAT-negative donors developed infection. Among the recipients with donor-derived HCV (dd-HCV), 30-day and 1-year survival rates were 92.5% and 90.4%, respectively. This study therefore shows that with the availability of DAAs, the use of HCV-positive donor hearts may serve to expand the donor pool, reducing waitlist times and cardiac-related mortality.

Click to read the study in JAMA Cardiology

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

#VisualAbstract: Dapagliflozin does not reduce albuminuria in patients with heart failure and type 2 diabetes (DAPPER study)

#VisualAbstract: Semaglutide improves symptoms in patients with heart failure

Semaglutide improves symptoms in patients with heart failure

Tags: direct acting antiviralsheart failureHeart Transplanthepatitis C
Previous Post

Dietary supplement use during chemotherapy and survival outcomes of patients with breast cancer enrolled in a cooperative group clinical trial (SWOG S0221)

Next Post

#VisualAbstract: Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis

RelatedReports

#VisualAbstract: Dapagliflozin does not reduce albuminuria in patients with heart failure and type 2 diabetes (DAPPER study)
StudyGraphics

#VisualAbstract: Dapagliflozin does not reduce albuminuria in patients with heart failure and type 2 diabetes (DAPPER study)

December 1, 2023
#VisualAbstract: Semaglutide improves symptoms in patients with heart failure
StudyGraphics

#VisualAbstract: Semaglutide improves symptoms in patients with heart failure

November 15, 2023
Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial
Cardiology

Semaglutide improves symptoms in patients with heart failure

November 10, 2023
Safety of MRI for patients with legacy cardiac devices
Cardiology

Adaptive resynchronization shows no benefit over conventional biventricular resynchronization in patients with heart failure

October 17, 2023
Next Post
#VisualAbstract: Rectal indomethacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients

#VisualAbstract: Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis

Mental disorders and intimate partner violence perpetrated by men towards women

Ultrasound enhances gastrointestinal absorption of drugs at low frequencies

Association between use of multiple classes of antibiotic in infancy an allergic disease in childhood

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Seriesâ„¢ textbook.

Subscription Options

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • A Begginer’s Guide to Understanding Odds Ratios, Confidence Intervals, and P-values
  • #VisualAbstract: Intravenous Levothyroxine Does Not Increase the Number of Heart Transplants in Unstable Brain-Dead Potential Heart Donors
  • #VisualAbstract: Dapagliflozin does not reduce albuminuria in patients with heart failure and type 2 diabetes (DAPPER study)
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classicsâ„¢
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options